{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:19:36Z","timestamp":1785161976921,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302023"],"award-info":[{"award-number":["82302023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171770"],"award-info":[{"award-number":["82171770"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101884"],"award-info":[{"award-number":["82101884"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10067-024-07227-5","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T07:47:57Z","timestamp":1732348077000},"page":"327-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Serum level of IFN-\u03bb is elevated in idiopathic inflammatory myopathies"],"prefix":"10.1007","volume":"44","author":[{"given":"Jingping","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangmei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niansheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7779-7347","authenticated-orcid":false,"given":"Shuyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"issue":"18","key":"7227_CR1","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 372(18):1734\u20131747","journal-title":"N Engl J Med"},{"issue":"12","key":"7227_CR2","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955\u20131964","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"7227_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11926-018-0733-5","volume":"20","author":"PW Wolstencroft","year":"2018","unstructured":"Wolstencroft PW, Fiorentino DF (2018) Dermatomyositis clinical and pathological phenotypes associated with myositis-specific autoantibodies. Curr Rheumatol Rep 20(5):28","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"7227_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11926-019-0871-4","volume":"21","author":"D Li","year":"2019","unstructured":"Li D, Tansley SL (2019) Juvenile dermatomyositis-clinical phenotypes. Curr Rheumatol Rep 21(12):74","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"7227_CR5","first-page":"450","volume":"63","author":"DA Isenberg","year":"1986","unstructured":"Isenberg DA, Rowe D, Shearer M, Novick D, Beverley PC (1986) Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy. Clin Exp Immunol 63(2):450\u2013458","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"7227_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","volume":"20","author":"AM Emslie-Smith","year":"1989","unstructured":"Emslie-Smith AM, Arahata K, Engel AG (1989) Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 20(3):224\u2013231","journal-title":"Hum Pathol"},{"issue":"5","key":"7227_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ana.20464","volume":"57","author":"SA Greenberg","year":"2005","unstructured":"Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R et al (2005) Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57(5):664\u2013678","journal-title":"Ann Neurol"},{"issue":"11","key":"7227_CR8","doi-asserted-by":"publisher","first-page":"a028423","DOI":"10.1101\/cshperspect.a028423","volume":"10","author":"H Negishi","year":"2018","unstructured":"Negishi H, Taniguchi T, Yanai H (2018) The interferon (IFN) class of cytokines and the IFN regulatory factor (IRF) transcription factor family. Cold Spring Harb Perspect Biol 10(11):a028423","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"7227_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/ng.2521","volume":"45","author":"L Prokunina-Olsson","year":"2013","unstructured":"Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H et al (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45(2):164\u2013171","journal-title":"Nat Genet"},{"issue":"1","key":"7227_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","volume":"43","author":"HM Lazear","year":"2015","unstructured":"Lazear HM, Nice TJ, Diamond MS (2015) Interferon-lambda: immune functions at barrier surfaces and beyond. Immunity 43(1):15\u201328","journal-title":"Immunity"},{"issue":"4","key":"7227_CR11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/hep.26657","volume":"59","author":"CR Bolen","year":"2014","unstructured":"Bolen CR, Ding S, Robek MD, Kleinstein SH (2014) Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression. Hepatology 59(4):1262\u20131272","journal-title":"Hepatology"},{"issue":"8","key":"7227_CR12","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ni.3212","volume":"16","author":"A Wack","year":"2015","unstructured":"Wack A, Terczynska-Dyla E, Hartmann R (2015) Guarding the frontiers: the biology of type III interferons. Nat Immunol 16(8):802\u2013809","journal-title":"Nat Immunol"},{"issue":"11","key":"7227_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007420","volume":"14","author":"K Pervolaraki","year":"2018","unstructured":"Pervolaraki K, Rastgou Talemi S, Albrecht D, Bormann F, Bamford C, Mendoza JL et al (2018) Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance. PLoS Pathog 14(11):e1007420","journal-title":"PLoS Pathog"},{"issue":"3","key":"7227_CR14","doi-asserted-by":"publisher","first-page":"R88","DOI":"10.1186\/ar3363","volume":"13","author":"Q Wu","year":"2011","unstructured":"Wu Q, Yang Q, Lourenco E, Sun H, Zhang Y (2011) Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus its correlation with disease activity. Arthritis Res Ther 13(3):R88","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"7227_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/RHU.0000000000000581","volume":"23","author":"LM Amezcua-Guerra","year":"2017","unstructured":"Amezcua-Guerra LM, Marquez-Velasco R, Chavez-Rueda AK, Castillo-Martinez D, Masso F, Paez A et al (2017) Type III interferons in systemic lupus erythematosus: association between interferon lambda3, disease activity, and anti-Ro\/SSA antibodies. J Clin Rheumatol 23(7):368\u2013375","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"7227_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/08916934.2012.730587","volume":"46","author":"Q Wu","year":"2013","unstructured":"Wu Q, Yang Q, Sun H, Li M, Zhang Y, La Cava A (2013) Serum IFN-lambda1 is abnormally elevated in rheumatoid arthritis patients. Autoimmunity 46(1):40\u201343","journal-title":"Autoimmunity"},{"issue":"5","key":"7227_CR17","doi-asserted-by":"publisher","first-page":"R228","DOI":"10.1186\/ar4067","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang F, Xu L, Feng X, Guo D, Tan W, Zhang M (2012) Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis. Arthritis Res Ther 14(5):R228","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"7227_CR18","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/art.10273","volume":"46","author":"W Huang","year":"2002","unstructured":"Huang W, Sinha J, Newman J, Reddy B, Budhai L, Furie R et al (2002) The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus. Arthritis Rheum 46(6):1554\u20131562","journal-title":"Arthritis Rheum"},{"issue":"1","key":"7227_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2018-000296","volume":"5","author":"MK Hritzo Ahye","year":"2018","unstructured":"Hritzo Ahye MK, Golding A (2018) Cytoplasmic FOXO1 identifies a novel disease-activity associated B cell phenotype in SLE. Lupus Sci Med 5(1):e000296","journal-title":"Lupus Sci Med"},{"issue":"4","key":"7227_CR20","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X et al (2018) Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49(4):725\u201339 e6","journal-title":"Immunity"},{"issue":"11","key":"7227_CR21","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.4049\/jimmunol.2100339","volume":"207","author":"JL Barnas","year":"2021","unstructured":"Barnas JL, Albrecht J, Meednu N, Alzamareh DF, Baker C, McDavid A et al (2021) B cell activation and plasma cell differentiation are promoted by IFN-lambda in systemic lupus erythematosus. J Immunol 207(11):2660\u20132672","journal-title":"J Immunol"},{"issue":"10","key":"7227_CR22","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","volume":"178","author":"C Wei","year":"2007","unstructured":"Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J et al (2007) A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 178(10):6624\u20136633","journal-title":"J Immunol"},{"key":"7227_CR23","doi-asserted-by":"crossref","unstructured":"Seto N, Torres-Ruiz JJ, Carmona-Rivera C, Pinal-Fernandez I, Pak K, Purmalek MM, et al. Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies. JCI Insight. 2020;5(3)","DOI":"10.1172\/jci.insight.134189"},{"issue":"11","key":"7227_CR24","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/j.cell.2021.03.056","volume":"184","author":"M Ota","year":"2021","unstructured":"Ota M, Nagafuchi Y, Hatano H, Ishigaki K, Terao C, Takeshima Y et al (2021) Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases. Cell 184(11):3006\u201321 e17","journal-title":"Cell"},{"issue":"3","key":"7227_CR25","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z et al (2021) clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb) 2(3):100141","journal-title":"Innovation (Camb)"},{"issue":"6","key":"7227_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P (2015) The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst 1(6):417\u2013425","journal-title":"Cell Syst"},{"issue":"Suppl 2","key":"7227_CR27","doi-asserted-by":"publisher","first-page":"i82","DOI":"10.1136\/annrheumdis-2011-200587","volume":"71","author":"FW Miller","year":"2012","unstructured":"Miller FW (2012) New approaches to the assessment and treatment of the idiopathic inflammatory myopathies. Ann Rheum Dis 71(Suppl 2):i82\u2013i85","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"7227_CR28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41577-019-0182-z","volume":"19","author":"L Ye","year":"2019","unstructured":"Ye L, Schnepf D, Staeheli P (2019) Interferon-lambda orchestrates innate and adaptive mucosal immune responses. Nat Rev Immunol 19(10):614\u2013625","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"7227_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1055\/s-0039-1685187","volume":"40","author":"T Barba","year":"2019","unstructured":"Barba T, Mainbourg S, Nasser M, Lega JC, Cottin V (2019) Lung diseases in inflammatory myopathies. Semin Respir Crit Care Med 40(2):255\u2013270","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"7227_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/BOR.0000000000000653","volume":"31","author":"L Gallay","year":"2019","unstructured":"Gallay L, Mouchiroud G, Chazaud B (2019) Interferon-signature in idiopathic inflammatory myopathies. Curr Opin Rheumatol 31(6):634\u2013642","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"7227_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12955","volume":"31","author":"L Bolko","year":"2021","unstructured":"Bolko L, Jiang W, Tawara N, Landon-Cardinal O, Anquetil C, Benveniste O et al (2021) The role of interferons type I, II and III in myositis: a review. Brain Pathol 31(3):e12955","journal-title":"Brain Pathol"},{"issue":"1","key":"7227_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ni873","volume":"4","author":"P Sheppard","year":"2003","unstructured":"Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE et al (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4(1):63\u201368","journal-title":"Nat Immunol"},{"issue":"6","key":"7227_CR33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1084\/jem.20021553","volume":"197","author":"L Bennett","year":"2003","unstructured":"Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J et al (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197(6):711\u2013723","journal-title":"J Exp Med"},{"issue":"1","key":"7227_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2016-000170","volume":"3","author":"A Zickert","year":"2016","unstructured":"Zickert A, Oke V, Parodis I, Svenungsson E, Sundstrom Y, Gunnarsson I (2016) Interferon (IFN)-lambda is a potential mediator in lupus nephritis. Lupus Sci Med 3(1):e000170","journal-title":"Lupus Sci Med"},{"issue":"12","key":"7227_CR35","doi-asserted-by":"publisher","first-page":"e1193","DOI":"10.1212\/WNL.0000000000008128","volume":"93","author":"I Pinal-Fernandez","year":"2019","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, Pak K, Plotz P, Miller FW et al (2019) Identification of distinctive interferon gene signatures in different types of myositis. Neurology 93(12):e1193\u2013e1204","journal-title":"Neurology"},{"issue":"1","key":"7227_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029161","volume":"7","author":"D Wong","year":"2012","unstructured":"Wong D, Kea B, Pesich R, Higgs BW, Zhu W, Brown P et al (2012) Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases. PLoS ONE 7(1):e29161","journal-title":"PLoS ONE"},{"issue":"3","key":"7227_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/gene.2011.61","volume":"13","author":"SA Greenberg","year":"2012","unstructured":"Greenberg SA, Higgs BW, Morehouse C, Walsh RJ, Kong SW, Brohawn P et al (2012) Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. Genes Immun 13(3):207\u2013213","journal-title":"Genes Immun"},{"issue":"11","key":"7227_CR38","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.autrev.2014.05.009","volume":"13","author":"D Poddighe","year":"2014","unstructured":"Poddighe D, Cavagna L, Brazzelli V, Bruni P, Marseglia GL (2014) A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. Autoimmun Rev 13(11):1142\u20131148","journal-title":"Autoimmun Rev"},{"issue":"5","key":"7227_CR39","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/art.42785","volume":"76","author":"A Fukada","year":"2024","unstructured":"Fukada A, Fujisawa T, Hozumi H, Koda K, Akamatsu T, Oyama Y et al (2024) Prognostic role of interferon-lambda3 in anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated interstitial lung disease. Arthritis Rheumatol 76(5):796\u2013805","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"7227_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10067-017-3877-1","volume":"37","author":"L Zhu","year":"2018","unstructured":"Zhu L, Yin Z, Ju B, Zhang J, Wang Y, Lv X et al (2018) Altered frequencies of memory B cells in new-onset systemic lupus erythematosus patients. Clin Rheumatol 37(1):205\u2013212","journal-title":"Clin Rheumatol"},{"key":"7227_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fmed.2020.00085","volume":"7","author":"X You","year":"2020","unstructured":"You X, Zhang R, Shao M, He J, Chen J, Liu J et al (2020) Double negative B cell is associated with renal impairment in systemic lupus erythematosus and acts as a marker for nephritis remission. Front Med (Lausanne) 7:85","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"7227_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13075-015-0580-y","volume":"17","author":"Z Mahmood","year":"2015","unstructured":"Mahmood Z, Muhammad K, Schmalzing M, Roll P, Dorner T, Tony HP (2015) CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis. Arthritis Res Ther 17(1):61","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"7227_CR43","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.4049\/jimmunol.1502448","volume":"197","author":"N Claes","year":"2016","unstructured":"Claes N, Fraussen J, Vanheusden M, Hellings N, Stinissen P, Van Wijmeersch B et al (2016) Age-associated B cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients. J Immunol 197(12):4576\u20134583","journal-title":"J Immunol"},{"issue":"5","key":"7227_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/ard.2010.139949","volume":"70","author":"AP Liao","year":"2010","unstructured":"Liao AP, Salajegheh M, Nazareno R, Kagan JC, Jubin RG, Greenberg SA (2010) Interferon is associated with type 1 interferon-inducible gene expression in dermatomyositis. Ann Rheum Dis 70(5):831\u2013836","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"7227_CR45","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/bjd.15006","volume":"176","author":"C Huard","year":"2017","unstructured":"Huard C, Gulla SV, Bennett DV, Coyle AJ, Vleugels RA, Greenberg SA (2017) Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon beta in dermatomyositis. Br J Dermatol 176(5):1224\u20131230","journal-title":"Br J Dermatol"},{"issue":"1","key":"7227_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/14397595.2014.900843","volume":"25","author":"Y Horai","year":"2015","unstructured":"Horai Y, Koga T, Fujikawa K, Takatani A, Nishino A, Nakashima Y et al (2015) Serum interferon-alpha is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis. Mod Rheumatol 25(1):85\u201389","journal-title":"Mod Rheumatol"},{"key":"7227_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773352","volume":"12","author":"A Nombel","year":"2021","unstructured":"Nombel A, Fabien N, Coutant F (2021) Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol 12:773352","journal-title":"Front Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07227-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07227-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07227-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T14:07:38Z","timestamp":1736777258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07227-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["7227"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07227-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The studies involving human participants were reviewed and approved by the Institutional Ethical Committee of First Affiliated Hospital, Sun Yat-sen University (ethics number: [2021]824). The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}